JPL Wealth Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$34.1K Buy
177
+167
+1,670% +$18K 0.01% 257
2026
Q2
$701 Buy
10
+5
+100% +$259 ﹤0.01% 1358
2026
Q1
$254 Buy
+5
New +$233 ﹤0.01% 1389
2025
Q4
– Sell
-5
Closed -$130 – 737
2025
Q3
$130 Buy
+5
New +$139 ﹤0.01% 1162

Other funds holding MRNA

JPL Wealth Management's MRNA Position: Q3 2026 in Review

JPL Wealth Management increased its Moderna (MRNA) stake by 1,670% in Q3 2026, buying an estimated $18K and bringing the position to 177 shares worth $34.1K. The position accounts for 0.01% of the portfolio, ranked #257.

JPL Wealth Management first reported a position in MRNA in Q3 2025 and has held it in 4 quarters since. 1,053 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • JPL Wealth Management held 177 shares of Moderna worth $34.1K as of Q3 2026.
  • JPL Wealth Management bought 167 Moderna shares in Q3 2026, an estimated $18K.
  • Moderna made up 0.01% of JPL Wealth Management's portfolio in Q3 2026, its #257 holding.
  • JPL Wealth Management first reported a position in Moderna in Q3 2025 and has held it in 4 quarters since.
  • 1,053 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on JPL Wealth Management's 13F filing for Q3 2026, filed 13 Nov 2026.